Computational Methodologies in the Exploration of Marine Natural Product Leads

Computational methodologies are assisting the exploration of marine natural products (MNPs) to make the discovery of new leads more efficient, to repurpose known MNPs, to target new metabolites on the basis of genome analysis, to reveal mechanisms of action, and to optimize leads. In silico efforts in drug discovery of NPs have mainly focused on two tasks: dereplication and prediction of bioactivities. The exploration of new chemical spaces and the application of predicted spectral data must be included in new approaches to select species, extracts, and growth conditions with maximum probabilities of medicinal chemistry novelty. In this review, the most relevant current computational dereplication methodologies are highlighted. Structure-based (SB) and ligand-based (LB) chemoinformatics approaches have become essential tools for the virtual screening of NPs either in small datasets of isolated compounds or in large-scale databases. The most common LB techniques include Quantitative Structure–Activity Relationships (QSAR), estimation of drug likeness, prediction of adsorption, distribution, metabolism, excretion, and toxicity (ADMET) properties, similarity searching, and pharmacophore identification. Analogously, molecular dynamics, docking and binding cavity analysis have been used in SB approaches. Their significance and achievements are the main focus of this review.

[1]  John H. Van Drie,et al.  Computer-aided drug design: the next 20 years , 2007, J. Comput. Aided Mol. Des..

[2]  Neetika Nath,et al.  CASSIS and SMIPS: promoter-based prediction of secondary metabolite gene clusters in eukaryotic genomes , 2015, Bioinform..

[3]  M. Diederich,et al.  Metabolomic Tools to Assess the Chemistry and Bioactivity of Endophytic Aspergillus Strain , 2017, Chemistry & biodiversity.

[4]  NEW TRICKS FOR OLD DRUGS , 1982 .

[5]  R. Abagyan,et al.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. , 2006, Analytical chemistry.

[6]  Lyn H. Jones,et al.  Applications of chemogenomic library screening in drug discovery , 2017, Nature Reviews Drug Discovery.

[7]  Hiroshi Mamitsuka,et al.  Current status and prospects of computational resources for natural product dereplication: a review , 2016, Briefings Bioinform..

[8]  J. Kirchmair,et al.  Data Resources for the Computer-Guided Discovery of Bioactive Natural Products , 2017, J. Chem. Inf. Model..

[9]  Roland E Dolle,et al.  Historical overview of chemical library design. , 2011, Methods in molecular biology.

[10]  V. Tiwari,et al.  Astaxanthin ameliorates behavioral and biochemical alterations in in-vitro and in-vivo model of neuropathic pain , 2018, Neuroscience Letters.

[11]  Roger G. Linington,et al.  Insights into Secondary Metabolism from a Global Analysis of Prokaryotic Biosynthetic Gene Clusters , 2014, Cell.

[12]  Antony J. Williams,et al.  ChemSpider:: An Online Chemical Information Resource , 2010 .

[13]  Calvin Yu-Chian Chen,et al.  TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico , 2011, PloS one.

[14]  J. V. van Maarseveen,et al.  Total Synthesis of Aquatolide. , 2015, Organic Letters.

[15]  H. Guan,et al.  Discovery of DNA Topoisomerase I Inhibitors with Low-Cytotoxicity Based on Virtual Screening from Natural Products , 2017, Marine drugs.

[16]  Youngsoo Kim,et al.  NPCARE: database of natural products and fractional extracts for cancer regulation , 2017, Journal of Cheminformatics.

[17]  R. Edrada-Ebel,et al.  Metabolomics and dereplication strategies in natural products. , 2013, Methods in molecular biology.

[18]  Masanori Arita,et al.  Identifying epimetabolites by integrating metabolome databases with mass spectrometry cheminformatics , 2017, Nature Methods.

[19]  Peter Ertl,et al.  Natural Product-likeness Score and Its Application for Prioritization of Compound Libraries , 2008, J. Chem. Inf. Model..

[20]  Juho Rousu,et al.  Metabolite identification and molecular fingerprint prediction through machine learning , 2012, Bioinform..

[21]  F. Barona-Gómez,et al.  Phylogenomic Analysis of Natural Products Biosynthetic Gene Clusters Allows Discovery of Arseno-Organic Metabolites in Model Streptomycetes , 2016, bioRxiv.

[22]  E. Deplazes Molecular Simulations of Disulfide-Rich Venom Peptides with Ion Channels and Membranes , 2017, Molecules.

[23]  M. Elyashberg,et al.  Synergistic Combination of CASE Algorithms and DFT Chemical Shift Predictions: A Powerful Approach for Structure Elucidation, Verification, and Revision. , 2016, Journal of natural products.

[24]  Yu Kang,et al.  Cheminformatic Insight into the Differences between Terrestrial and Marine Originated Natural Products , 2018, J. Chem. Inf. Model..

[25]  C. Ávila,et al.  Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer’s Disease Therapeutic Agents , 2017, Marine drugs.

[26]  U. Hentschel,et al.  Dereplication Strategies for Targeted Isolation of New Antitrypanosomal Actinosporins A and B from a Marine Sponge Associated-Actinokineospora sp. EG49 , 2014, Marine drugs.

[27]  D. Newman,et al.  Drugs and Drug Candidates from Marine Sources: An Assessment of the Current “State of Play” , 2016, Planta Medica.

[28]  Bradley S Moore,et al.  Lessons from the past and charting the future of marine natural products drug discovery and chemical biology. , 2012, Chemistry & biology.

[29]  Russ Greiner,et al.  Competitive fragmentation modeling of ESI-MS/MS spectra for putative metabolite identification , 2013, Metabolomics.

[30]  Tilmann Weber,et al.  The evolution of genome mining in microbes - a review. , 2016, Natural product reports.

[31]  Lars Ridder,et al.  Substructure-based annotation of high-resolution multistage MS(n) spectral trees. , 2012, Rapid communications in mass spectrometry : RCM.

[32]  Florian Rasche,et al.  Towards de novo identification of metabolites by analyzing tandem mass spectra , 2008, ECCB.

[33]  Yoshiyuki Sakaki,et al.  Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis , 2003, Nature Biotechnology.

[34]  J. Briggs,et al.  Interactions of acetylcholine binding site residues contributing to nicotinic acetylcholine receptor gating: role of residues Y93, Y190, K145 and D200. , 2013, Journal of molecular graphics & modelling.

[35]  Juho Rousu,et al.  Metabolite identification through multiple kernel learning on fragmentation trees , 2014, Bioinform..

[36]  David S. Wishart,et al.  HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..

[37]  Diether Lambrechts,et al.  Improved metabolite identification with MIDAS and MAGMa through MS/MS spectral dataset-driven parameter optimization , 2016, Metabolomics.

[38]  Federico Gago,et al.  Structural rationale for the cross-resistance of tumor cells bearing the A399V variant of elongation factor eEF1A1 to the structurally unrelated didemnin B, ternatin, nannocystin A and ansatrienin B , 2017, Journal of Computer-Aided Molecular Design.

[39]  Theodora Katsila,et al.  Computational approaches in target identification and drug discovery , 2016, Computational and structural biotechnology journal.

[40]  János Bérdy,et al.  Bioactive microbial metabolites. , 2005, The Journal of antibiotics.

[41]  Roger G. Linington,et al.  Genome-Directed Lead Discovery: Biosynthesis, Structure Elucidation, and Biological Evaluation of Two Families of Polyene Macrolactams against Trypanosoma brucei. , 2015, ACS chemical biology.

[42]  Jens Meiler,et al.  Discovery of 2‐(2‐Benzoxazoyl amino)‐4‐Aryl‐5‐Cyanopyrimidine as Negative Allosteric Modulators (NAMs) of Metabotropic Glutamate Receptor 5 (mGlu5): From an Artificial Neural Network Virtual Screen to an In Vivo Tool Compound , 2012, ChemMedChem.

[43]  C. George Priya Doss,et al.  Bioactivity of Marine Streptomyces sp. VITJS4: Interactions of Cytotoxic Phthalate Derivatives with Human Topoisomerase II α: An In Silico Molecular Docking Analysis , 2016, Interdisciplinary Sciences: Computational Life Sciences.

[44]  Ximing Xu,et al.  Application of reverse docking for target prediction of marine compounds with anti-tumor activity. , 2017, Journal of molecular graphics & modelling.

[45]  Jean-Louis Reymond,et al.  Virtual Exploration of the Ring Systems Chemical Universe , 2017, J. Chem. Inf. Model..

[46]  Kristian Fog Nielsen,et al.  Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking , 2016, Nature Biotechnology.

[47]  Antony J. Williams,et al.  Computer‐assisted structure elucidation of natural products with limited 2D NMR data: application of the StrucEluc system , 2003 .

[48]  Polina Mamoshina,et al.  Design of efficient computational workflows for in silico drug repurposing. , 2017, Drug discovery today.

[49]  Santosh A. Khedkar,et al.  Successful applications of computer aided drug discovery: moving drugs from concept to the clinic. , 2010, Current topics in medicinal chemistry.

[50]  Zhe-Sheng Chen,et al.  Lamellarin O, a Pyrrole Alkaloid from an Australian Marine Sponge, Ianthella sp., Reverses BCRP Mediated Drug Resistance in Cancer Cells , 2014, Marine drugs.

[51]  Bertrand Plainchont,et al.  Recent advances in the structure elucidation of small organic molecules by the LSD software , 2013, Magnetic resonance in chemistry : MRC.

[52]  E. Troche-Pesqueira,et al.  Computer-Assisted 3D Structure Elucidation of Natural Products using Residual Dipolar Couplings. , 2017, Angewandte Chemie.

[53]  A. Defant,et al.  Discorhabdin alkaloids from Antarctic Latrunculia spp. sponges as a new class of cholinesterase inhibitors. , 2017, European journal of medicinal chemistry.

[54]  Robert D. Finn,et al.  HMMER web server: interactive sequence similarity searching , 2011, Nucleic Acids Res..

[55]  Christoph Steinbeck,et al.  Building blocks for automated elucidation of metabolites: natural product-likeness for candidate ranking , 2014, BMC Bioinformatics.

[56]  J. Bérdy Bioactive Microbial Metabolites A Personal View , 2005 .

[57]  A. Hernández Daranas,et al.  Marine Longilenes, Oxasqualenoids with Ser-Thr Protein Phosphatase 2A Inhibition Activity , 2018, Marine drugs.

[58]  Qin Wang,et al.  Dihedral Angle-Based Sampling of Natural Product Polyketide Conformations: Application to Permeability Prediction , 2016, J. Chem. Inf. Model..

[59]  Wolfgang Sippl,et al.  AfroDb: A Select Highly Potent and Diverse Natural Product Library from African Medicinal Plants , 2013, PloS one.

[60]  David J Newman,et al.  Natural products: a continuing source of novel drug leads. , 2013, Biochimica et biophysica acta.

[61]  G. Schneider,et al.  Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide. , 2016, Angewandte Chemie.

[62]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[63]  S. Böcker,et al.  Searching molecular structure databases with tandem mass spectra using CSI:FingerID , 2015, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Julio Caballero,et al.  In silico Comparison of Antimycobacterial Natural Products with Known Antituberculosis Drugs , 2013, J. Chem. Inf. Model..

[65]  Gajendra P. S. Raghava,et al.  NPACT: Naturally Occurring Plant-based Anti-cancer Compound-Activity-Target database , 2012, Nucleic Acids Res..

[66]  J. Rita,et al.  The correct structure of aquatolide-experimental validation of a theoretically-predicted structural revision. , 2012, Journal of the American Chemical Society.

[67]  Adriano D Andricopulo,et al.  Development of a natural products database from the biodiversity of Brazil. , 2013, Journal of natural products.

[68]  Petra Schneider,et al.  Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus , 2014, Proceedings of the National Academy of Sciences.

[69]  Steffen Neumann,et al.  MetFusion: integration of compound identification strategies. , 2013, Journal of mass spectrometry : JMS.

[70]  R. Altman,et al.  Predicting drug side-effects by chemical systems biology , 2009, Genome Biology.

[71]  Yi Sun,et al.  HIM-herbal ingredients in-vivo metabolism database , 2013, Journal of Cheminformatics.

[72]  Andrzej Joachimiak,et al.  High-throughput crystallography for structural genomics. , 2009, Current opinion in structural biology.

[73]  Chuipu Cai,et al.  Quantitative and Systems Pharmacology. 1. In Silico Prediction of Drug-Target Interactions of Natural Products Enables New Targeted Cancer Therapy , 2017, J. Chem. Inf. Model..

[74]  Virapong Prachayasittikul,et al.  Maximizing computational tools for successful drug discovery , 2015, Expert opinion on drug discovery.

[75]  Xiangyun Ye,et al.  Integrated discovery of FOXO1-DNA stabilizers from marine natural products to restore chemosensitivity to anti-EGFR-based therapy for metastatic lung cancer. , 2017, Molecular bioSystems.

[76]  John P. Overington,et al.  Can we rationally design promiscuous drugs? , 2006, Current opinion in structural biology.

[77]  Lars Ridder,et al.  Automatic Compound Annotation from Mass Spectrometry Data Using MAGMa. , 2014, Mass spectrometry.

[78]  Jie Li,et al.  SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug–target interactions and drug repositioning , 2016, Briefings Bioinform..

[79]  Kiyoshi Asai,et al.  Motif-Independent Prediction of a Secondary Metabolism Gene Cluster Using Comparative Genomics: Application to Sequenced Genomes of Aspergillus and Ten Other Filamentous Fungal Species , 2014, DNA research : an international journal for rapid publication of reports on genes and genomes.

[80]  Yukiko Matsuoka,et al.  systemsDock: a web server for network pharmacology-based prediction and analysis , 2016, Nucleic Acids Res..

[81]  A. Schuffenhauer,et al.  Charting biologically relevant chemical space: a structural classification of natural products (SCONP). , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[82]  Mohieddin Jafari,et al.  Updates on drug-target network; facilitating polypharmacology and data integration by growth of DrugBank database , 2015, Briefings Bioinform..

[83]  Edward W. Lowe,et al.  Computational Methods in Drug Discovery , 2014, Pharmacological Reviews.

[84]  H. Castro,et al.  Marine Diterpenes: Molecular Modeling of Thrombin Inhibitors with Potential Biotechnological Application as an Antithrombotic , 2017, Marine drugs.

[85]  W. Hopper,et al.  Ligand Based-Pharmacophore Modeling and Extended Bi oactivity Prediction for Salinosporamide A, B and C from Marine Actino mycetes Salinispora tropica. , 2017, Combinatorial chemistry & high throughput screening.

[86]  M. Grube,et al.  Chemical analysis of the Alphaproteobacterium strain MOLA1416 associated with the marine lichen Lichina pygmaea. , 2018, Phytochemistry.

[87]  Jing Li,et al.  Advanced tools in marine natural drug discovery. , 2016, Current opinion in biotechnology.

[88]  F. Sanger,et al.  Sequences, sequences, and sequences. , 1988, Annual review of biochemistry.

[89]  Ming Liu,et al.  Structure-based discovery of cytotoxic dimeric tetrahydroxanthones as potential topoisomerase I inhibitors from a marine-derived fungus. , 2018, European journal of medicinal chemistry.

[90]  M. Gordaliza,et al.  Aquatolide. A new type of humulane-related sesquiterpene lactone , 1989 .

[91]  Susana P. Gaudêncio,et al.  A Chemoinformatics Approach to the Discovery of Lead-Like Molecules from Marine and Microbial Sources En Route to Antitumor and Antibiotic Drugs , 2014, Marine drugs.

[92]  M. Elyashberg,et al.  Towards unbiased and more versatile NMR‐based structure elucidation: A powerful combination of CASE algorithms and DFT calculations , 2018, Magnetic resonance in chemistry : MRC.

[93]  Jee H Jung,et al.  Evaluation of the inhibitory effects of eckol and dieckol isolated from edible brown alga Eisenia bicyclis on human monoamine oxidases A and B , 2017, Archives of Pharmacal Research.

[94]  U. Hentschel,et al.  Metabolomic Tools for Secondary Metabolite Discovery from Marine Microbial Symbionts , 2014, Marine drugs.

[95]  Nicola Nosengo Can you teach old drugs new tricks? , 2016, Nature.

[96]  Wei Zhang,et al.  Design, synthesis and biological evaluation of tasiamide B derivatives as BACE1 inhibitors. , 2015, Bioorganic & medicinal chemistry.

[97]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[98]  Hassan Y. Ebrahim,et al.  Discovery of Novel Antiangiogenic Marine Natural Product Scaffolds , 2016, Marine drugs.

[99]  Zhuhua Luo,et al.  Antimicrobial activity and molecular docking studies of a novel anthraquinone from a marine-derived fungus Aspergillus versicolor , 2018, Natural product research.

[100]  D. Haft,et al.  SMURF: Genomic mapping of fungal secondary metabolite clusters. , 2010, Fungal genetics and biology : FG & B.

[101]  S. Skariyachan,et al.  Secondary metabolites extracted from marine sponge associated Comamonas testosteroni and Citrobacter freundii as potential antimicrobials against MDR pathogens and hypothetical leads for VP40 matrix protein of Ebola virus: an in vitro and in silico investigation , 2016, Journal of biomolecular structure & dynamics.

[102]  V. Masand,et al.  Computational strategies to explore antimalarial thiazine alkaloid lead compounds based on an Australian marine sponge Plakortis Lita , 2017, Journal of biomolecular structure & dynamics.

[103]  Won‐Kyo Jung,et al.  Purification and molecular docking study of angiotensin I-converting enzyme (ACE) inhibitory peptides from hydrolysates of marine sponge Stylotella aurantium , 2017 .

[104]  A. Siddique,et al.  The marine‐derived pachycladin diterpenoids as novel inhibitors of wild‐type and mutant EGFR , 2017, Biochemical pharmacology.

[105]  Alan L Harvey,et al.  Natural products in drug discovery. , 2008, Drug discovery today.

[106]  Alina Bora,et al.  PLS-DA - Docking Optimized Combined Energetic Terms (PLSDA-DOCET) Protocol: A Brief Evaluation , 2011, J. Chem. Inf. Model..

[107]  R. Vijayakrishnan Structure-based drug design and modern medicine. , 2009, Journal of postgraduate medicine.

[108]  H. Mario Geysen,et al.  A guide to drug discovery: Combinatorial compound libraries for drug discovery: an ongoing challenge , 2003, Nature Reviews Drug Discovery.

[109]  W. Hopper,et al.  Biological Activity of Sporolides A and B from Salinispora tropica: in silico Target Prediction Using Ligand‐Based Pharmacophore Mapping and in vitro activity Validation on HIV‐1 Reverse Transcriptase , 2014, Chemical biology & drug design.

[110]  Tilmann Weber,et al.  The secondary metabolite bioinformatics portal: Computational tools to facilitate synthetic biology of secondary metabolite production , 2016, Synthetic and systems biotechnology.

[111]  John J. Irwin,et al.  ZINC 15 – Ligand Discovery for Everyone , 2015, J. Chem. Inf. Model..

[112]  G. D. Davis,et al.  QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ). , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[113]  Bradley S Moore,et al.  Prioritizing Natural Product Diversity in a Collection of 146 Bacterial Strains Based on Growth and Extraction Protocols. , 2017, Journal of natural products.

[114]  Zhiyong Li,et al.  Marine actinobacteria associated with marine organisms and their potentials in producing pharmaceutical natural products , 2014, Applied Microbiology and Biotechnology.

[115]  Robert R. Lewis,et al.  In silico identification software (ISIS): a machine learning approach to tandem mass spectral identification of lipids , 2012, Bioinform..

[116]  Yoonkyung Park,et al.  Marine Peptides and Their Anti-Infective Activities , 2015, Marine drugs.

[117]  Susana P. Gaudêncio,et al.  Dereplication: racing to speed up the natural products discovery process. , 2015, Natural product reports.

[118]  Matej Oresic,et al.  MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data , 2010, BMC Bioinformatics.

[119]  D. E. Clark What has computer-aided molecular design ever done for drug discovery? , 2006, Expert opinion on drug discovery.

[120]  Kai Blin,et al.  antiSMASH 4.0—improvements in chemistry prediction and gene cluster boundary identification , 2017, Nucleic Acids Res..

[121]  J. Scannell,et al.  Diagnosing the decline in pharmaceutical R&D efficiency , 2012, Nature Reviews Drug Discovery.

[122]  Josep Saurí,et al.  Unequivocal determination of complex molecular structures using anisotropic NMR measurements , 2017, Science.

[123]  Erin E. Carlson,et al.  Integrated metabolomics approach facilitates discovery of an unpredicted natural product suite from Streptomyces coelicolor M145. , 2013, ACS chemical biology.

[124]  D. Faulkner Marine natural products. , 2000, Natural product reports.

[125]  Philip A. Gale,et al.  QSAR analysis of substituent effects on tambjamine anion transporters , 2015, Chemical science.

[126]  Henry Lin,et al.  Structure-based discovery of opioid analgesics with reduced side effects , 2016, Nature.

[127]  Jiansong Fang,et al.  Predictions of BuChE Inhibitors Using Support Vector Machine and Naive Bayesian Classification Techniques in Drug Discovery , 2013, J. Chem. Inf. Model..

[128]  Michael A Fischbach,et al.  Computational approaches to natural product discovery. , 2015, Nature chemical biology.

[129]  William Fenical,et al.  Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica , 2007, Proceedings of the National Academy of Sciences.

[130]  T. Zhu,et al.  Chetracins E and F, cytotoxic epipolythiodioxopiperazines from the marine-derived fungus Acrostalagmus luteoalbus HDN13-530 , 2018 .

[131]  P. Permi,et al.  Genome mining expands the chemical diversity of the cyanobactin family to include highly modified linear peptides. , 2013, Chemistry & biology.

[132]  Michael A. Skinnider,et al.  Genomes to natural products PRediction Informatics for Secondary Metabolomes (PRISM) , 2015, Nucleic acids research.

[133]  W. Wohlleben,et al.  Antibiotic drug discovery , 2016, Microbial biotechnology.

[134]  Gang Fu,et al.  PubChem Substance and Compound databases , 2015, Nucleic Acids Res..

[135]  Antony J. Williams,et al.  Structure Elucidation from 2D NMR Spectra Using the StrucEluc Expert System: Detection and Removal of Contradictions in the Data , 2004, J. Chem. Inf. Model..

[136]  Christoph Methfessel,et al.  Marine Natural Products Acting on the Acetylcholine-Binding Protein and Nicotinic Receptors: From Computer Modeling to Binding Studies and Electrophysiology , 2014, Marine drugs.

[137]  Johann Gasteiger,et al.  Chemoinformatics: Achievements and Challenges, a Personal View , 2016, Molecules.

[138]  Matthias Müller-Hannemann,et al.  In silico fragmentation for computer assisted identification of metabolite mass spectra , 2010, BMC Bioinformatics.

[139]  M. Kinch,et al.  An analysis of FDA-approved drugs: natural products and their derivatives. , 2016, Drug discovery today.

[140]  Sebastian Böcker,et al.  Mining molecular structure databases: Identification of small molecules based on fragmentation mass spectrometry data. , 2017, Mass spectrometry reviews.

[141]  P Jeffrey Conn,et al.  Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity , 2010, Molecular Pharmacology.

[142]  B. Moore,et al.  Identification of Thiotetronic Acid Antibiotic Biosynthetic Pathways by Target-directed Genome Mining. , 2015, ACS chemical biology.

[143]  Y. Kashman,et al.  Cycloshermilamine D, a new pyridoacridine from the marine tunicate cystodytes violatinctus. , 2000, Journal of natural products.

[144]  J. Encinar,et al.  An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs , 2017, Molecules.

[145]  E. Márquez,et al.  Molecular modeling studies of bromopyrrole alkaloids as potential antimalarial compounds: a DFT approach , 2018, Medicinal Chemistry Research.

[146]  Li-xin Gao,et al.  Design and synthesis of novel 1,2-dithiolan-4-yl benzoate derivatives as PTP1B inhibitors. , 2015, Bioorganic & Medicinal Chemistry Letters.

[147]  Christoph Steinbeck,et al.  SENECA: A Platform-Independent, Distributed, and Parallel System for Computer-Assisted Structure Elucidation in Organic Chemistry , 2001, J. Chem. Inf. Comput. Sci..

[148]  Jesús Martín,et al.  Combined LC/UV/MS and NMR Strategies for the Dereplication of Marine Natural Products , 2016, Planta Medica.

[149]  Antony J. Williams,et al.  Structure Elucidator: A Versatile Expert System for Molecular Structure Elucidation from 1D and 2D NMR Data and Molecular Fragments , 2004, J. Chem. Inf. Model..

[150]  Lorenz M Mayr,et al.  The Future of High-Throughput Screening , 2008, Journal of biomolecular screening.

[151]  Dilip K. Rai,et al.  Current Status and Future Prospects of Marine Natural Products (MNPs) as Antimicrobials , 2017, Marine drugs.

[152]  Dayong Shi,et al.  BPN, a marine-derived PTP1B inhibitor, activates insulin signaling and improves insulin resistance in C2C12 myotubes. , 2018, International journal of biological macromolecules.

[153]  Li Qinying,et al.  Dicitrinone D, an antimitotic polyketide isolated from the marine-derived fungus Penicillium citrinum , 2017 .

[154]  J. Choi,et al.  α-Glucosidase and Protein Tyrosine Phosphatase 1B Inhibitory Activity of Plastoquinones from Marine Brown Alga Sargassum serratifolium , 2017, Marine drugs.

[155]  Oliver Fiehn,et al.  LipidBlast - in-silico tandem mass spectrometry database for lipid identification , 2013, Nature Methods.

[156]  Carla M. Saunders,et al.  Application of Computational Chemical Shift Prediction Techniques to the Cereoanhydride Structure Problem—Carboxylate Complications , 2017, Marine drugs.

[157]  Stefan Wetzel,et al.  Biology-oriented synthesis. , 2011, Angewandte Chemie.

[158]  Susana P. Gaudêncio,et al.  QSAR-Assisted Virtual Screening of Lead-Like Molecules from Marine and Microbial Natural Sources for Antitumor and Antibiotic Drug Discovery , 2015, Molecules.

[159]  Abimael D Rodríguez,et al.  Marine Pharmacology in 2009–2011: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and other Miscellaneous Mechanisms of Action † , 2013, Marine drugs.

[160]  Oliver Fiehn,et al.  MINEs: open access databases of computationally predicted enzyme promiscuity products for untargeted metabolomics , 2015, Journal of Cheminformatics.

[161]  B. Barrell,et al.  Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2) , 2002, Nature.

[162]  A. Kerber,et al.  Molecules in Silico: The Generation of Structural Formulae and Its Applications , 2004 .

[163]  J. Zucko,et al.  ClustScan: an integrated program package for the semi-automatic annotation of modular biosynthetic gene clusters and in silico prediction of novel chemical structures , 2008, Nucleic acids research.

[164]  Chris S. Thomas,et al.  Natural Product Discovery Using Planes of Principal Component Analysis in R (PoPCAR) , 2017, Metabolites.

[165]  C. Cuevas,et al.  On the Mechanism of Action of Dragmacidins I and J, Two New Representatives of a New Class of Protein Phosphatase 1 and 2A Inhibitors , 2018, ACS omega.

[166]  George Papadatos,et al.  The ChEMBL database in 2017 , 2016, Nucleic Acids Res..

[167]  Y. Guitton,et al.  Automated Detection of Natural Halogenated Compounds from LC-MS Profiles-Application to the Isolation of Bioactive Chlorinated Compounds from Marine-Derived Fungi. , 2016, Analytical Chemistry.

[168]  B. Bowen,et al.  MIDAS: a database-searching algorithm for metabolite identification in metabolomics. , 2014, Analytical chemistry.

[169]  T. Ng,et al.  Antibacterial products of marine organisms , 2015, Applied Microbiology and Biotechnology.

[170]  R. W. Hansen,et al.  Journal of Health Economics , 2016 .

[171]  Sebastian Böcker,et al.  New kids on the block: novel informatics methods for natural product discovery. , 2014, Natural product reports.

[172]  Stefan Günther,et al.  StreptomeDB 2.0—an extended resource of natural products produced by streptomycetes , 2015, Nucleic Acids Res..

[173]  Mingzi M. Zhang,et al.  Using natural products for drug discovery: the impact of the genomics era , 2017, Expert opinion on drug discovery.